Current disease status-First occurrence of the cancer Posts on Medivizor
Navigation Menu

Current disease status-First occurrence of the cancer Posts on Medivizor

Combined S-1 chemotherapy improves the outcomes of patients with advanced colorectal cancer

Combined S-1 chemotherapy improves the outcomes of patients with advanced colorectal cancer

Posted by on Jul 1, 2020 in Colorectal cancer | 0 comments

In a nutshell This study compared two different chemotherapy treatments in metastatic colorectal cancer (mCRC; spread to other parts of the body). Researchers suggested that 24-hour infused irinotecan (Camptosar) plus oral S-1 (Teysuno) chemotherapy and bevacizumab (Avastin) is well tolerated and associated with improved outcomes. Some background...

Read More

Comparing the long-term effects of two intensity modulated radiation therapies in localized prostate cancer

Comparing the long-term effects of two intensity modulated radiation therapies in localized prostate cancer

Posted by on Jun 28, 2020 in Prostate cancer | 0 comments

In a nutshell The study compared the long-term effects of moderate hypofractionated intensity-modulated radiation therapy (H-IMRT) and conventionally fractionated IMRT (C-IMRT) on outcomes in patients with localized prostate cancer (PC). The authors found that H-IMRT was similarly effective compared to C-IMRT after 10 years of therapy in such...

Read More

Can biological drug pembrolizumab added to chemotherapy improve treatment results long-term for patients with non-small cell lung cancer?

Can biological drug pembrolizumab added to chemotherapy improve treatment results long-term for patients with non-small cell lung cancer?

Posted by on Jun 13, 2020 in Lung cancer | 0 comments

In a nutshell This study examined if the addition of pembrolizumab (Keytruda) to chemotherapy with pemetrexed (Alimta) and platinum improved treatment results long-term for patients with advanced non-small-cell lung cancer (NSCLC). The authors found that patients who received pembrolizumab with chemotherapy had improved survival and...

Read More

Evaluating the impact of long term androgen deprivation therapy and radiotherapy after prostate surgery in patients with high risk of relapse

Posted by on Apr 30, 2020 in Prostate cancer | 0 comments

In a nutshell The study looked at the effects of long term androgen deprivation therapy (LT-ADT), pelvic lymph node radiotherapy (PLNRT) and prostate bed radiotherapy (PBRT) in patients with prostate cancer and high risk of recurrence after prostate surgery. They found an increase in survival without cancer worsening in these patients.  Some...

Read More

Can specialized imaging techniques improve how chemo-radiotherapy is administered in locally advanced non-small cell lung cancer?

Posted by on Apr 21, 2020 in Lung cancer | 0 comments

In a nutshell This study set out to compare conventional-dose chemoradiotherapy (CRT) to reduced CRT based on 18F-FDG PET in locally advanced non-small cell lung cancer (NSCLC). The investigators found that 18F-FDG PET-based CRT improved tumor control without increasing side effects in these patients.  Some background NSCLC accounts for...

Read More

Does the frequency of radiotherapy doses impact its effectiveness and safety for patients with localized prostate cancer?

Posted by on Apr 12, 2020 in Prostate cancer | 0 comments

In a nutshell This study examined if the frequency of the same dose of radiotherapy (RT) changed the effectiveness and safety of patients with localized prostate cancer (PC). The results showed that RT that was given weekly was as effective and safe as RT given every other day. Some background Radiotherapy (RT) is an effective treatment for...

Read More

Do biological drugs work better alone or in combination with other drugs for patients with advanced non-small cell lung cancer who previously received treatment?

Posted by on Apr 7, 2020 in Lung cancer | 0 comments

In a nutshell This study compared if anti-PD-1 biological drugs were more effective alone or when used with other drugs to treat patients with advanced non-small cell lung cancer who had previously received treatment. The results showed that the combination of anti-PD-1 and other drugs such as chemotherapy improved patients’ survival more than...

Read More

Reviewing treatment options for patients with uveal melanoma

Posted by on Mar 13, 2020 in Melanoma | 0 comments

In a nutshell This guideline reviewed treatment options for patients with newly diagnosed uveal melanoma. Some background The uvea is the middle layer of the eye. It is made up of the iris (the colored part of the eye), the ciliary body (a muscle in the eye), and the choroid (a layer of tissue in the back of the eye). In uveal melanoma (UM), tumors...

Read More

Benefits of therapy for early stage breast cancer

Posted by on Feb 29, 2020 in Breast cancer | 0 comments

In a nutshell This paper is a document that was developed at a breast cancer conference by a number of experts in the field. It outlines suggested treatment for early-stage breast cancer. The experts concluded that patients and doctors should work together and discuss the benefit of treating early-stage breast cancer in comparison with the potential...

Read More

Surgical removal of a primary tumor in newly diagnosed metastatic breast cancer

Posted by on Feb 22, 2020 in Breast cancer | 0 comments

In a nutshell This study wanted to find out if surgically removing the main tumor in breast cancer which has spread throughout the body would impact the survival of the patient. The study found that removing the primary tumor resulted in a longer overall survival in patients with breast cancer that has spread. Some background A common treatment for...

Read More

Pelvic radiotherapy followed by systemic therapy and surgery improves survival in patients with advanced rectal cancer

Posted by on Feb 22, 2020 in Colorectal cancer | 0 comments

In a nutshell This study investigated the effectiveness of pelvic radiotherapy (PRT) followed by chemotherapy and surgery in advanced rectal cancer. Researchers suggested that this combined treatment is associated with improved survival rates. Some background Rectal cancer affects 44,180 people each year in the US. Up to 80% of these people present...

Read More